Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6:15–15. https://doi.org/10.1038/s41413-018-0016-9.
Article
CAS
Google Scholar
Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, Kavanaugh A, McInnes IB, Solomon DH, Strand V, Yamamoto K. Rheumatoid arthritis. Nat Rev Dis Prim. 2018;4:18001. https://doi.org/10.1038/nrdp.2018.1.
Article
Google Scholar
Almutairi K, Nossent J, Preen D, Keen H, Inderjeeth C. The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int. 2021. https://doi.org/10.1007/s00296-020-04731-0.
Article
Google Scholar
Australian Institute of Health and Welfare. Rheumatoid arthritis 2020. https://www.aihw.gov.au/reports/chronic-musculoskeletal-conditions/rheumatoid-arthritis/contents/who-gets-rheumatoid-arthritis.
Shapira Y, Agmon-Levin N, Shoenfeld Y. Geoepidemiology of autoimmune rheumatic diseases. Nat Rev Rheumatol. 2010;6(8):468–76. https://doi.org/10.1038/nrrheum.2010.86.
Article
CAS
Google Scholar
Al Mutairi KB, Nossent JC, Inderjeeth CA. Validity of self-reported diagnosis of rheumatoid arthritis. J Rheumatol. 2020;47(5):781. https://doi.org/10.3899/jrheum.191401.
Article
Google Scholar
Australian Institute of Health and Welfare. National indicators for monitoring osteoarthritis, rheumatoid arthritis and osteoporosis 2006. p. 55. https://www.aihw.gov.au/getmedia/ceb67de7-3497-472b-9bbc-50477eac32af/nimorao.pdf.aspx?inline=true.
Hanly JG, Thompson K, Skedgel C. The use of administrative health care databases to identify patients with rheumatoid arthritis. Open Access Rheumatol. 2015;7(6):69–75.
Article
Google Scholar
Fox DM. Evidence of evidence-based health policy: the politics of systematic reviews in coverage decisions. Health Aff. 2005;24(1):114–22.
Article
Google Scholar
Sibthorpe B, Kliewer E, Smith L. Record linkage in Australian epidemiological research: health benefits, privacy safeguards and future potential. Aust N Z J Public Health. 1995;19(3):250–6. https://doi.org/10.1111/j.1753-6405.1995.tb00439.x.
Article
CAS
Google Scholar
Chini F, Pezzotti P, Orzella L, Borgia P, Guasticchi G. Can we use the pharmacy data to estimate the prevalence of chronic conditions? A comparison of multiple data sources. BMC Public Health. 2011;11:688. https://doi.org/10.1186/1471-2458-11-688.
Article
Google Scholar
O’Dell JR. Therapeutic strategies for rheumatoid arthritis. N Engl J Med. 2004;350(25):2591–602.
Article
CAS
Google Scholar
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–7. https://doi.org/10.1016/s0140-6736(07)61602-x.
Article
Google Scholar
Nossent JC, Raymond W, Keen H, Preen DB, Inderjeeth CA. Infection rates before and after diagnosis of IgA vasculitis in childhood: a population-wide study using non-exposed matched controls. J Rheumatol. 2020;47(3):424–30. https://doi.org/10.3899/jrheum.190110.
Article
Google Scholar
Ognjenovic M, Raymond W, Inderjeeth C, Keen H, Preen D, Nossent J. The risk and consequences of vertebral fracture in patients with ankylosing spondylitis: a population-based data linkage study. J Rheumatol. 2020;47(11):1629–36. https://doi.org/10.3899/jrheum.190675.
Article
Google Scholar
Kelman CW, Bass AJ, Holman CD. Research use of linked health data—a best practice protocol. Aust N Z J Public Health. 2002;26(3):251–5.
Article
CAS
Google Scholar
Lacaille D, Anis AH, Guh DP, Esdaile JM. Gaps in care for rheumatoid arthritis: a population study. Arthritis Rheum. 2005;53(2):241–8. https://doi.org/10.1002/art.21077.
Article
Google Scholar
Almutairi K, Inderjeeth C, Preen DB, Keen H, Rogers K, Nossent J. The accuracy of administrative health data for identifying patients with rheumatoid arthritis: a retrospective validation study using medical records in Western Australia. Rheumatol Int. 2021;41(4):741–50. https://doi.org/10.1007/s00296-021-04811-9.
Article
Google Scholar
Medicare Australia. Pharmaceutical benefits schedule item reports 2020. http://medicarestatistics.humanservices.gov.au/statistics/pbs_item.jsp.
Australian Bureau of Statistics. Population by age and sex 2014. http://stat.data.abs.gov.au/Index.aspx?DataSetCode=ABS_ERP_ASGS2016.
World Health Organisation. ATC/DDD Index 2021. https://www.whocc.no/atc_ddd_index/.
Buckley N. Australian medicines handbook. Australia: Australian Medicines Handbook Pty Ltd; 2021.
Google Scholar
Allaire S, Wolfe F, Niu J, Zhang Y, Zhang B, LaValley M. Evaluation of the effect of anti-tumor necrosis factor agent use on rheumatoid arthritis work disability: the jury is still out. Arthritis Rheum. 2008;59(8):1082–9. https://doi.org/10.1002/art.23923.
Article
Google Scholar
Sergeant JC, Hyrich KL, Anderson J, Kopec-Harding K, Hope HF, Symmons DPM, Co-Investigators R, Barton A, Verstappen SMM. Prediction of primary non-response to methotrexate therapy using demographic, clinical and psychosocial variables: results from the UK Rheumatoid Arthritis Medication Study (RAMS). Arthritis Res Ther. 2018;20(1):147. https://doi.org/10.1186/s13075-018-1645-5.
Article
CAS
Google Scholar
Ciocci A, Buratti L, Coari G, Di Franco M, Iagnocco AM, Mauceri MT, Serio A. Rheumatoid arthritis: frequency of hospitalization and evaluation of economic burden. Reumatismo. 2001;53(3):215–22. https://doi.org/10.4081/reumatismo.2001.215.
Article
Google Scholar
Almutairi K, Nossent J, Preen D, Keen H, Inderjeeth C. The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int. 2021;41:863–77. https://doi.org/10.1007/s00296-020-04731-0.
Article
Google Scholar
Tobon GJ, Youinou P, Saraux A. The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. J Autoimmun. 2010;35(1):10–4. https://doi.org/10.1016/j.jaut.2009.12.009.
Article
Google Scholar
Sung YK, Cho SK, Choi CB, Bae SC. Prevalence and incidence of rheumatoid arthritis in South Korea. Rheumatol Int. 2013;33(6):1525–32. https://doi.org/10.1007/s00296-012-2590-2.
Article
Google Scholar
Rat AC, Boissier MC. Rheumatoid arthritis: direct and indirect costs. Jt Bone Spine. 2004;71(6):518–24. https://doi.org/10.1016/j.jbspin.2004.01.003.
Article
Google Scholar
Harrison C, Henderson J, Miller G, Britt H. The prevalence of diagnosed chronic conditions and multimorbidity in Australia: a method for estimating population prevalence from general practice patient encounter data. PLoS ONE. 2017;12(3):e0172935. https://doi.org/10.1371/journal.pone.0172935.
Article
CAS
Google Scholar
Englund M, Jöud A, Geborek P, Felson DT, Jacobsson LT, Petersson IF. Prevalence and incidence of rheumatoid arthritis in southern Sweden 2008 and their relation to prescribed biologics. Rheumatology. 2010;49(8):1563–9. https://doi.org/10.1093/rheumatology/keq127.
Article
Google Scholar
Cho SK, Sung YK, Choi CB, Kwon JM, Lee EK, Bae SC. Development of an algorithm for identifying rheumatoid arthritis in the Korean National Health Insurance claims database. Rheumatol Int. 2013;33(12):2985–2892. https://doi.org/10.1007/s00296-013-2833-x.
Article
Google Scholar
Almutairi K, Nossent J, Preen DB, Keen H, Inderjeeth C. The temporal association between hospital admissions, biological therapy usage and direct health care costs in rheumatoid arthritis patients. Rheumatol Int. 2021. https://doi.org/10.1007/s00296-021-04985-2.
Article
Google Scholar
Smolen JS, Landewé RB, Bijlsma JW, Burmester GR, Dougados M, Kerschbaumer A, McInnes IB, Sepriano A, Van Vollenhoven RF, De Wit M. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs 2020: 2019 update.
Wilske KR, Healey LA. Challenging the therapeutic pyramid: a new look at treatment strategies for rheumatoid arthritis. J Rheumatol Suppl. 1990;25:4–7.
CAS
Google Scholar
Rai SK, Avina-Zubieta JA, McCormick N, De Vera MA, Lacaille D, Sayre EC, Choi HK. Trends in gout and rheumatoid arthritis hospitalizations in Canada from 2000 to 2011. Arthritis Care Res (Hoboken). 2017;69(5):758–62. https://doi.org/10.1002/acr.23012.
Article
Google Scholar
Finckh A, Gilbert B, Hodkinson B, Bae SC, Thomas R, Deane KD, Alpizar-Rodriguez D, Lauper K. Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol. 2022;18(10):591–602. https://doi.org/10.1038/s41584-022-00827-y.
Article
Google Scholar
Roberts LJ, Lamont EG, Lim I, Sabesan S, Barrett C. Telerheumatology: an idea whose time has come. Intern Med J. 2012;42(10):1072–8. https://doi.org/10.1111/j.1445-5994.2012.02931.x.
Article
CAS
Google Scholar
National Rural Health Alliance. Poverty in rural & remote Australia 2017. https://www.ruralhealth.org.au/sites/default/files/publications/nrha-factsheet-povertynov2017.pdf.
Putrik P, Ramiro S, Keszei AP, Hmamouchi I, Dougados M, Uhlig T, Kvien TK, Boonen A. Lower education and living in countries with lower wealth are associated with higher disease activity in rheumatoid arthritis: results from the multinational COMORA study. Ann Rheum Dis. 2016;75(3):540–6. https://doi.org/10.1136/annrheumdis-2014-206737.
Article
Google Scholar
Mehta J. Juvenile Idiopathic Arthritis (JIA)—Pediatrics—MSD Manual Professional Edition 2020. https://www.msdmanuals.com/en-au/professional/pediatrics/juvenile-idiopathic-arthritis/juvenile-idiopathic-arthritis-jia?query=Juvenile%20Idiopathic%20Arthritis%20(JIA).
Australian Institute of Health and Welfare. A snapshot of juvenile arthritis 2013. https://www.aihw.gov.au/getmedia/125411fa-7c84-4753-aec1-0a0d76a63a2d/14900.pdf.aspx?inline=true#:~:text=Etanercept%20and%20adalimumab%20are%20biologic,and%20adalimumab%20since%20November%202010.